Cross Country Healthcare (CCRN) Price & Analysis

Compare

255 Followers

CCRN Stock Chart & Stats

Day’s Range― - ―

52-Week Range$9.58 - $18.33

Previous CloseN/A

Volume369.88K

Average Volume (3M)260.58K

Market Cap

$433.44M

Enterprise Value$345.60M

Total Cash (Recent Filing)$81.19M

Total Debt (Recent Filing)$2.77M

Price to Earnings (P/E)―

Beta0.05

Next Earnings

Oct 29, 2025

EPS Estimate

0.04

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding32,761,993

10 Day Avg. Volume213,531

30 Day Avg. Volume260,583

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.80

Enterprise Value/Revenue0.29

Enterprise Value/Gross Profit1.46

Enterprise Value/Ebitda26.98

Forecast

1Y Price Target

$16.74

Price Target Upside26.53% Upside

Rating ConsensusHold

Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say

Acquisition AgreementCCRN entered into a definitive agreement to be acquired by Aya Healthcare for $615M in cash, or $18.61 per share, a 67% premium to the prior closing price.

Cost ManagementThe company successfully minimized costs, with SG&A down 17% year-over-year and almost no bad debt expense.

Bears Say

Regulatory Approval UncertaintyThe transaction is expected to be completed pending regulatory approval, which is far from certain with the shares trading 32% below the offer.

Revenue DeclineQ1/25 revenue of $293.4 million came in lower than the consensus of $305.4 million, while declining -23% YOY due to the continuation of softer demand conditions across the healthcare travel staffing industry.

Cross Country Healthcare News

Cross Country Healthcare reports Q2 adjusted EPS (1c), consensus 6c

Reports Q2 revenue $274.07M, consensus $292.19M. “Our second quarter results were in line with expectation, reflecting a combination...

22d ago

CCRN

Cross Country Healthcare Reports Q2 2025 Financial Results

Cross Country Healthcare ( ($CCRN) ) has released its Q2 earnings. Here is a breakdown of the information...

22d ago

CCRN

Cautious Hold Rating for Cross Country Healthcare Amid Revenue Decline and Acquisition Uncertainty

William Blair analyst Trevor Romeo has maintained their neutral stance on CCRN stock, giving a Hold rating on...

22d ago

CCRN

Cross Country Healthcare Reports Q2 2025 Financial Results

Cross Country Healthcare ( ($CCRN) ) just unveiled an update. Cross Country Healthcare announced its second quarter 2025...

22d ago

CCRN

Is CCRN a Buy, Before Earnings?

Cross Country Healthcare (CCRN) is scheduled to report 2nd quarter earnings on 07/30/2025. Regarding Q2 estimates, Wall Street...

1M ago

CCRN

Hold Rating on Cross Country Healthcare Amid Acquisition Uncertainty and Financial Challenges

In a report released today, Kevin Steinke from Barrington maintained a Hold rating on Cross Country Healthcare (CCRN...

2M ago

CCRN

Cross Country Healthcare deal challenge weighed by FTC, CTFN says

The FTC is “seriously weighing” a challenge to Cross Country Healthcare’s (CCRN) deal to be acquired, reported CTFN,...

3M ago

CCRN

Cross Country Healthcare price target lowered to $16.50 from $18.61 at UBS

UBS lowered the firm’s price target on Cross Country Healthcare (CCRN) to $16.50 from $18.61 and keeps a...

4M ago

CCRN

Cross Country Healthcare Reports Q1 2025 Financial Results

Cross Country Healthcare ( ($CCRN) ) has released its Q1 earnings. Here is a breakdown of the information...

4M ago

CCRN

Cautious Hold Rating for Cross Country Healthcare Amid Revenue Decline and Market Challenges

William Blair analyst Trevor Romeo has maintained their neutral stance on CCRN stock, giving a Hold rating today....

4M ago

CCRN

Cross Country Healthcare Reports Q1 2025 Financial Results

Cross Country Healthcare ( ($CCRN) ) just unveiled an announcement. Cross Country Healthcare announced its financial results for...

4M ago

CCRN

Cross Country Healthcare reports Q1 adjusted EPS 6c, consensus 7c

Reports Q1 revenue $293.41M, consensus $314.82M. “Our first quarter results reflect solid execution with both Homecare and Physician...

4M ago

CCRN

CCRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Cross Country Healthcare (CCRN) is scheduled to report 1st quarter earnings on 04/30/2025. Regarding Q1 estimates, Wall Street...

4M ago

CCRN

Hold Rating Maintained for Cross Country Healthcare Amidst Profitability Decline and Pending Aya Healthcare Merger

Barrington analyst Kevin Steinke maintained a Hold rating on Cross Country Healthcare (CCRN – Research Report) today and...

6M ago

CCRN

CCRN FAQ

What was Cross Country Healthcare’s price range in the past 12 months?

Cross Country Healthcare lowest stock price was $9.58 and its highest was $18.33 in the past 12 months.

What is Cross Country Healthcare’s market cap?

Cross Country Healthcare’s market cap is $433.44M.

When is Cross Country Healthcare’s upcoming earnings report date?

Cross Country Healthcare’s upcoming earnings report date is Oct 29, 2025 which is in 61 days.

How were Cross Country Healthcare’s earnings last quarter?

Cross Country Healthcare released its earnings results on Aug 06, 2025. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of $0.057 by -$0.067.

Is Cross Country Healthcare overvalued?

According to Wall Street analysts Cross Country Healthcare’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Cross Country Healthcare pay dividends?

Cross Country Healthcare does not currently pay dividends.

What is Cross Country Healthcare’s EPS estimate?

Cross Country Healthcare’s EPS estimate is 0.04.

How many shares outstanding does Cross Country Healthcare have?

Cross Country Healthcare has 32,761,993 shares outstanding.

What happened to Cross Country Healthcare’s price movement after its last earnings report?

Cross Country Healthcare reported an EPS of -$0.01 in its last earnings report, missing expectations of $0.057. Following the earnings report the stock price went down -4.351%.

Which hedge fund is a major shareholder of Cross Country Healthcare?

Currently, no hedge funds are holding shares in CCRN

Cross Country Healthcare Stock Smart Score

Neutral

Fundamentals

Return on Equity

-1.96%

Trailing 12-Months

Asset Growth

-8.14%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Cross Country Healthcare

Cross Country Healthcare, Inc. (CCRN) is a leading provider of healthcare staffing and workforce solutions in the United States. The company specializes in connecting healthcare facilities with qualified professionals, including nurses, allied health personnel, and other medical staff. CCRN offers a range of services, including travel nurse staffing, per diem staffing, and workforce management solutions, catering to hospitals, clinics, and other healthcare organizations across various sectors.

Cross Country Healthcare (CCRN) Earnings & Revenues

Historic Earnings Reports

CCRN Stock 12 Month Forecast

Average Price Target

$16.74

▲(26.53% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","19":"$19","12.25":"$12.25","14.5":"$14.5","16.75":"$16.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":18.61,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$18.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":16.74,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$16.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$13.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,12.25,14.5,16.75,19],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.04,13.468461538461538,13.896923076923077,14.325384615384614,14.753846153846153,15.182307692307692,15.61076923076923,16.03923076923077,16.467692307692307,16.896153846153844,17.324615384615385,17.75307692307692,18.181538461538462,{"y":18.61,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.04,13.324615384615385,13.609230769230768,13.893846153846154,14.178461538461537,14.463076923076922,14.747692307692306,15.032307692307691,15.316923076923075,15.60153846153846,15.886153846153844,16.170769230769228,16.455384615384613,{"y":16.74,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.04,13.036923076923076,13.033846153846152,13.03076923076923,13.027692307692307,13.024615384615384,13.02153846153846,13.018461538461539,13.015384615384615,13.012307692307692,13.009230769230768,13.006153846153847,13.003076923076923,{"y":13,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.55,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.92,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.1,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.33,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.52,"date":1733011200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":18.16,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.22,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.16,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.87,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.53,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.15,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.17,"date":1751328000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":13.04,"date":1754006400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >